Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1349

1.

Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.

Okada N, Iwama S, Okuji T, Kobayashi T, Yasuda Y, Wada E, Onoue T, Goto M, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Hase T, Morise M, Kanda M, Yokota K, Hashimoto N, Ando M, Fujimoto Y, Nagino M, Kodera Y, Fujishiro M, Hibi H, Sone M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H.

Br J Cancer. 2020 Feb 3. doi: 10.1038/s41416-020-0736-7. [Epub ahead of print]

PMID:
32009131
2.

Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study.

Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K.

BJU Int. 2020 Jan 28. doi: 10.1111/bju.15020. [Epub ahead of print]

PMID:
31991511
3.

D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.

Kanda Y, Kimura SI, Iino M, Fukuda T, Sakaida E, Oyake T, Yamaguchi H, Fujiwara SI, Jo Y, Okamoto A, Fujita H, Takamatsu Y, Saburi Y, Matsumura I, Yamanouchi J, Shiratori S, Gotoh M, Nakamura S, Tamura K; Japan Febrile Neutropenia Study Group.

J Clin Oncol. 2020 Jan 24:JCO1901916. doi: 10.1200/JCO.19.01916. [Epub ahead of print]

PMID:
31977270
4.

Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis.

Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Biol Blood Marrow Transplant. 2020 Jan 18. pii: S1083-8791(20)30018-5. doi: 10.1016/j.bbmt.2020.01.007. [Epub ahead of print]

PMID:
31962165
5.

Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments.

Sassa N, Yokoyama Y, Nishida Y, Yamada S, Uchida H, Kajiyama H, Nagino M, Kodera Y, Gotoh M.

Int J Clin Oncol. 2020 Jan 16. doi: 10.1007/s10147-020-01620-1. [Epub ahead of print]

PMID:
31950376
6.

Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.

Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Ishida R, Kamihira O, Sano T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Hattori R, Gotoh M, Tsuzuki T.

Prostate. 2020 Feb;80(3):284-290. doi: 10.1002/pros.23942. Epub 2019 Dec 20.

PMID:
31860754
7.

A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure.

Muramatsu T, Funahashi Y, Yamamoto A, Sassa N, Matsukawa Y, Gotoh M.

Nagoya J Med Sci. 2019 Nov;81(4):707-710. doi: 10.18999/nagjms.81.4.707.

8.

Propensity score-matched comparison of docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant intraductal carcinoma of the prostate.

Yamamoto A, Kato M, Hattori K, Naito Y, Tochigi K, Sano T, Kawanishi H, Ishikawa T, Yuba T, Hattori R, Gotoh M, Tsuzuki T.

BJU Int. 2019 Dec 12. doi: 10.1111/bju.14970. [Epub ahead of print]

PMID:
31833179
9.

Development of a model predicting the risk of eight major postoperative complications after esophagectomy based on 10 826 cases in the Japan National Clinical Database.

Ohkura Y, Miyata H, Konno H, Udagawa H, Ueno M, Shindoh J, Kumamaru H, Wakabayashi G, Gotoh M, Mori M.

J Surg Oncol. 2019 Dec 10. doi: 10.1002/jso.25800. [Epub ahead of print]

PMID:
31823377
10.

[Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice].

Matsukawa Y, Funahashi Y, Gotoh M.

Nihon Yakurigaku Zasshi. 2019;154(5):265-269. doi: 10.1254/fpj.154.265. Review. Japanese.

PMID:
31735756
11.

Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]Pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 2.

Kaieda A, Takahashi M, Fukuda H, Okamoto R, Morimoto S, Gotoh M, Miyazaki T, Hori Y, Unno S, Kawamoto T, Tanaka T, Itono S, Takagi T, Sugimoto H, Okada K, Lane W, Sang BC, Saikatendu K, Matsunaga S, Miwatashi S.

ChemMedChem. 2019 Dec 17;14(24):2093-2101. doi: 10.1002/cmdc.201900373. Epub 2019 Nov 7.

PMID:
31697454
12.

The effect of mirabegron on bladder blood flow in a rat model of bladder outlet obstruction.

Majima T, Matsukawa Y, Funahashi Y, Kato M, Yamamoto T, Gotoh M.

World J Urol. 2019 Oct 29. doi: 10.1007/s00345-019-02939-9. [Epub ahead of print]

PMID:
31664511
13.

Saturated fatty acid is a principal cause of anxiety-like behavior in diet-induced obese rats in relation to serum lysophosphatidyl choline level.

Nakajima S, Fukasawa K, Gotoh M, Murakami-Murofushi K, Kunugi H.

Int J Obes (Lond). 2019 Oct 21. doi: 10.1038/s41366-019-0468-z. [Epub ahead of print]

PMID:
31636375
14.

Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma.

Inamoto T, Sassa N, Hattori R, Ibuki N, Komura K, Minami K, Takai T, Uchimoto T, Saito K, Tanda N, Tsujino T, Sano T, Kato M, Tsuzuki T, Gotoh M, Azuma H.

Curr Urol. 2019 Jul;12(4):201-209. doi: 10.1159/000499305. Epub 2019 Jul 20.

15.

Basophil-expressing genes related with the efficacy of sublingual immunotherapy.

Gotoh M, Kaminuma O, Nakaya A, Saeki M, Nishimura T, Kitamura N, Hiroi T, Kimihiro Okubo A.

J Nippon Med Sch. 2019 Sep 30. doi: 10.1272/jnms.JNMS.2020_87-104. [Epub ahead of print]

16.

Oleic acid is a potent inducer for lipid droplet accumulation through its esterification to glycerol by diacylglycerol acyltransferase in primary cortical astrocytes.

Nakajima S, Gotoh M, Fukasawa K, Murakami-Murofushi K, Kunugi H.

Brain Res. 2019 Dec 15;1725:146484. doi: 10.1016/j.brainres.2019.146484. Epub 2019 Sep 25.

PMID:
31562840
17.

What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?

Matsukawa Y, Majima T, Takai S, Funahashi Y, Kato M, Gotoh M.

Urol Int. 2019;103(4):439-443. doi: 10.1159/000502661. Epub 2019 Sep 25.

PMID:
31554005
18.

Development and validation of grade-based prediction models for postoperative morbidity in gastric cancer resection using a Japanese web-based nationwide registry.

Haga Y, Miyata H, Tsuburaya A, Gotoh M, Yoshida K, Konno H, Seto Y, Fujiwara Y, Baba H.

Ann Gastroenterol Surg. 2019 Jun 20;3(5):544-551. doi: 10.1002/ags3.12269. eCollection 2019 Sep.

19.

Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516 217 cases).

Hata T, Ikeda M, Miyata H, Nomura M, Gotoh M, Sakon M, Yamamoto K, Wakabayashi G, Seto Y, Mori M, Doki Y.

Ann Gastroenterol Surg. 2019 Jul 22;3(5):534-543. doi: 10.1002/ags3.12275. eCollection 2019 Sep.

20.

Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.

Matsukawa Y, Yoshida M, Yamaguchi O, Takai S, Majima T, Funahashi Y, Yono M, Sekido N, Gotoh M.

Int J Urol. 2020 Jan;27(1):47-52. doi: 10.1111/iju.14121. Epub 2019 Sep 21.

PMID:
31542892
21.
22.

Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Sep 19. doi: 10.1038/s41409-019-0689-8. [Epub ahead of print] No abstract available.

PMID:
31537900
23.

A case of bulky pseudohyperplastic prostatic adenocarcinoma.

Narita T, Kondo A, Maeda M, Funahashi Y, Tanaka K, Gotoh M.

Aktuelle Urol. 2019 Sep 4. doi: 10.1055/a-0978-6148. [Epub ahead of print]

PMID:
31486059
24.

A case of metastatic prostate cancer treated with metastasectomy.

Miyata Y, Funahashi Y, Yamamoto A, Sassa N, Matsukawa Y, Gotoh M.

Aktuelle Urol. 2019 Aug 26. doi: 10.1055/a-0943-3647. [Epub ahead of print]

PMID:
31450244
25.

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.

Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y.

Allergol Int. 2020 Jan;69(1):104-110. doi: 10.1016/j.alit.2019.07.007. Epub 2019 Aug 14.

26.

2-Carba cyclic phosphatidic acid inhibits lipopolysaccharide-induced prostaglandin E2 production in a human macrophage cell line.

Shibaike Y, Gotoh M, Ogawa C, Nakajima S, Yoshikawa K, Kobayashi T, Murakami-Murofushi K.

Biochem Biophys Rep. 2019 Jul 19;19:100668. doi: 10.1016/j.bbrep.2019.100668. eCollection 2019 Sep.

27.

Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2017.

Hasegawa H, Takahashi A, Kakeji Y, Ueno H, Eguchi S, Endo I, Sasaki A, Takiguchi S, Takeuchi H, Hashimoto M, Horiguchi A, Masaki T, Marubashi S, Yoshida K, Konno H, Gotoh M, Miyata H, Seto Y.

Ann Gastroenterol Surg. 2019 May 20;3(4):426-450. doi: 10.1002/ags3.12258. eCollection 2019 Jul.

28.

Risk calculator for predicting postoperative pneumonia after gastroenterological surgery based on a national Japanese database.

Takesue Y, Miyata H, Gotoh M, Wakabayashi G, Konno H, Mori M, Kumamaru H, Ueda T, Nakajima K, Uchino M, Seto Y.

Ann Gastroenterol Surg. 2019 Apr 22;3(4):405-415. doi: 10.1002/ags3.12248. eCollection 2019 Jul.

29.

Surgical quality improvement programs in Japan and USA: Report from the collaborative projects between Japanese Society of Gastroenterological Surgery and American College of Surgeons National Surgical Quality Improvement Program.

Marubashi S, Liu JY, Miyata H, Cohen ME, Ko CY, Seto Y, Gotoh M.

Ann Gastroenterol Surg. 2019 Apr 22;3(4):343-351. doi: 10.1002/ags3.12250. eCollection 2019 Jul. Review.

30.

Comparison of the Uroflowmetry Parameter Results Between Transgender Males Undergoing Gender-Affirming Hormone Therapy and Age-Matched Cisgender Females: Preliminary Data.

Matsuo K, Ichihara K, Gotoh M, Masumori N.

Transgend Health. 2019 Jul 1;4(1):152-156. doi: 10.1089/trgh.2019.0025. eCollection 2019.

31.

[Mechanisms of allergen immunotherapy elucidated through integrated comparative analysis].

Kaminuma O, Gotoh M, Okubo K, Nakaya A, Hiroi T.

Nihon Yakurigaku Zasshi. 2019;154(1):23-27. doi: 10.1254/fpj.154.23. Review. Japanese.

PMID:
31308346
32.

Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan.

Yoshida I, Tamura K, Miyamoto T, Shimokawa M, Takamatsu Y, Nanya Y, Matsumura I, Gotoh M, Igarashi T, Takahashi T, Aiba K, Kumagai K, Ishizawa K, Kurita N, Usui N, Hatake K.

In Vivo. 2019 Jul-Aug;33(4):1355-1362. doi: 10.21873/invivo.11611.

33.

Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.

Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, Okamoto Y.

Allergol Int. 2019 Oct;68(4):494-505. doi: 10.1016/j.alit.2019.05.002. Epub 2019 Jun 27.

34.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

35.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S; JCOG UOSG.

J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.

PMID:
31251717
36.

Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney.

Tochigi K, Funahashi Y, Mori A, Matsukawa Y, Kato M, Gotoh M.

Nagoya J Med Sci. 2019 May;81(2):337-340. doi: 10.18999/nagjms.81.2.337.

37.

Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant.

Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Dec;54(12):2020-2026. doi: 10.1038/s41409-019-0585-2. Epub 2019 Jun 11.

PMID:
31186516
38.

Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomes.

Tanaka N, Nishimura K, Okajima E, Ina K, Ogawa O, Nagata H, Akakura K, Fujimoto K, Gotoh M, Teramukai S, Hirao Y.

Int J Urol. 2019 Aug;26(8):797-803. doi: 10.1111/iju.14009. Epub 2019 May 5.

PMID:
31055879
39.

Thrombospondin 1-mediated suppression of mast cell degranulation is involved in the efficacy of sublingual immunotherapy.

Kaminuma O, Kitamura N, Gotoh M, Shindo M, Watanabe N, Saeki M, Nishimura T, Mori A, Nemoto S, Tatsumi H, Okubo K, Hiroi T.

Allergol Int. 2019 Sep;68S:S9-S10. doi: 10.1016/j.alit.2019.03.007. Epub 2019 Apr 25. No abstract available.

40.

The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.

Kato M, Hirakawa A, Kobayashi Y Ms, Yamamoto A, Ishida R, Sano T, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T.

Prostate. 2019 Jul;79(10):1065-1070. doi: 10.1002/pros.23818. Epub 2019 Apr 26.

PMID:
31025722
41.

Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care.

Hirata K, Imamura M, Fujiwara T, Fukui T, Furukawa T, Gotoh M, Hakamada K, Ishiguro M, Kakeji Y, Konno H, Miyata H, Mori M, Okita K, Sato M, Shibata A, Takemasa I, Unno M, Yokoi K, Nishidate T, Nishiyama M.

Int J Clin Oncol. 2019 Sep;24(9):1161-1168. doi: 10.1007/s10147-019-01434-w. Epub 2019 Apr 22.

PMID:
31011913
42.

Investigation of the relationship between bladder function and sarcopenia using pressure flow studies in elderly male patients.

Majima T, Funahashi Y, Matsukawa Y, Inoue S, Sassa N, Kato M, Yamamoto T, Gotoh M.

Neurourol Urodyn. 2019 Jun;38(5):1417-1422. doi: 10.1002/nau.24001. Epub 2019 Apr 15.

PMID:
30989706
43.

Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database.

Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y.

Esophagus. 2019 Oct;16(4):362-370. doi: 10.1007/s10388-019-00672-1. Epub 2019 Apr 12.

44.

Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1.

Kaieda A, Takahashi M, Fukuda H, Okamoto R, Morimoto S, Gotoh M, Miyazaki T, Hori Y, Unno S, Kawamoto T, Tanaka T, Itono S, Takagi T, Sugimoto H, Okada K, Snell G, Bertsch R, Nguyen J, Sang BC, Miwatashi S.

ChemMedChem. 2019 May 17;14(10):1022-1030. doi: 10.1002/cmdc.201900129. Epub 2019 Apr 18.

PMID:
30945818
45.

Urodynamic analysis of the impact of diabetes mellitus on bladder function.

Majima T, Matsukawa Y, Funahashi Y, Takai S, Kato M, Yamamoto T, Gotoh M.

Int J Urol. 2019 Jun;26(6):618-622. doi: 10.1111/iju.13935. Epub 2019 Mar 18.

PMID:
30887604
46.

[GUIDE TO ALLERGEN IMMUNOTHERAPY IN JAPANESE CEDAR POLLINOSIS].

Gotoh M.

Arerugi. 2019;68(2):81-85. doi: 10.15036/arerugi.68.81. Japanese. No abstract available.

PMID:
30867364
47.

The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder.

Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, Stroupe A, Deshpande C, Delbecque L, Van Koeveringe G, Oelke M, Belal M, Bosch R, Blok B, Nitti V, Gotoh M, Takei M, Crawford B, Klaver M, Bongaerts D, Hakimi Z, Kos T, Abrams P.

Neurourol Urodyn. 2019 Mar;38(3):996-1004. doi: 10.1002/nau.23947. Epub 2019 Feb 22.

PMID:
30801826
48.

Usefulness of Shoulder36 in rotator cuff tears: Comparison with Simple Shoulder Test.

Kawakami J, Gotoh M, Matsuura K, Shin K, Fujito I, Tanaka A, Matsunaga S, Imai T, Nagamatsu T, Karasuyama M, Ohota T, Madokoro K, Shiba N.

J Orthop Surg (Hong Kong). 2019 Jan-Apr;27(1):2309499018819060. doi: 10.1177/2309499018819060.

PMID:
30798742
49.

Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies.

Matsukawa Y, Takai S, Majima T, Funahashi Y, Sassa N, Kato M, Yamamoto T, Gotoh M.

Neurourol Urodyn. 2019 Mar;38(3):941-949. doi: 10.1002/nau.23935. Epub 2019 Feb 19.

PMID:
30779375
50.

Thoracoscopic rib resection and reconstruction of chest wall: Our clinical experience.

Ueda Y, Nakagawa T, Tomioka Y, Toyazaki T, Gotoh M.

Asian J Endosc Surg. 2020 Jan;13(1):121-123. doi: 10.1111/ases.12691. Epub 2019 Feb 7.

PMID:
30734502

Supplemental Content

Support Center